Metformin Does Not Improve Outcomes in Early Breast Cancer

Metformin as adjuvant therapy did not improve invasive disease-free survival or overall survival rates, regardless of hormone receptor status.

Related Keywords

Canada ,New York ,United States ,Toronto ,Ontario ,Stephanie Bernik ,Pamelaj Goodwin ,University Of Toronto ,Icahn School Of Medicine At Mount Sinai ,More Research ,San Antonio Breast Cancer Symposium ,Medscape Medical ,Mount Sinai West ,Icahn School ,Mount Sinai ,Medscape Medical News ,Breast Cancer ,Alignant Breast Neoplasm ,Cancer ,Alignant Neoplasia ,Arcinoma ,Breast ,Obesity ,Bese ,Diabetes Mellitus ,Chemotherapy ,Weight Loss ,Weight Management ,Her2 Positive Breast Cancer ,Her2 Breast Cancer ,Lung Cancer ,Ung Carcinoma ,Ancer Lung ,Blindness ,Adjuvant Setting ,Adjuvant Therapy , ,Cancer Survivor ,Her2 Neu ,Poverty ,Inancial Hardship ,Antineoplastic Drug ,Nti Cancer Agents ,Pevaci ,